Ganoderma microsporum immunomodulatory protein (GMI) is a fungal immunomodulatory protein (FIP) identified from the Ganoderma microsporum mushroom. No CAS number is available for GMI. Its identification numbers in the United States (US) National Center for Biotechnology Information (NCBI) databank are GenBank GP714988.1 for FASTA sequence and GenBank AGU04723.1 for protein sequence. Ganoderma microsporum immunomodulatory protein (GMI) has shown anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) activity in vitro. There are no approved therapeutic indications for GMI.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
Please note: Due to the complexity and amount of studies regarding this compound—a Natural Health Product—increased cost is charged.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Ganoderma microsporum Immunomodulatory Protein (GMI), just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.